Introduction: Immediate postoperative period is very crucial and pain is maximum during first 24 hours. If patients are kept pain free during this period, it leads to vitally stable postoperative period, which in turn leads to early recovery. The aim of this study was to compare the analgesic efficacy of diclofenac sodium via two different routes, intramuscular (IM) and transdermal, in the management of postoperative pain.
INTRODUCTION
Abdominal hysterectomy is one of the most commonly performed surgeries. In 2003, over 600,000 hysterectomies were performed in the United States alone, of which over 90% were performed for benign conditions. 1 Pain following abdominal hysterectomy is inflammatory in nature occurring in response to tissue injury and is accompanied by a neurogenic inflammation. Injured tissues will release various substances, such as potassium, prostaglandins, histamine, bradykinins that are pronociceptive, and will also evoke an immune response. 2 These inflammatory and immune factors will sensitize the nociceptive receptors directly within the lesion and in the surrounding neurons. Primary hyperalgesia, which follows the release of these factors, may be measured as a lowered pain threshold in and around the lesion. The ability of nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit prostaglandin synthesis results in its anti-inflammatory activity, as well as contribute to its efficacy in relieving pain associated with inflammation. Secondary hyperalgesia is a phenomenon that refers to sensitization that occurs within the central nervous system. 3 Opioids interact with specific transmembrane G-protein-coupled binding sites termed opiate or opioid receptors. These receptors are located primarily in the spinal dorsal horn and other regions of the central nervous system that process affective and suffering aspects of pain perception. 4 Although ample evidences indicate that an efficacious postoperative pain treatment reduces patient morbidity and improves patient outcome, in accordance with recent studies about 50 to 70% of patients experience moderate to severe pain after surgery, indicating that postoperative pain remains poorly treated. 5 Various agents used for this purpose include acetaminophen, NSAIDs, opioids, glucocorticoids, etc. Among these, much literature is available for use of opioids to allay anxiety and postoperative pain. Because of documented problems with opioids like incomplete amnesia, histamine release, prolonged jOrapain postoperative respiratory depression, increased blood volume requirement secondary to vasodilatation and hypotension diminished the popularity of earlier opioids as a sole analgesic agent. 6 Nowadays apart from the traditional opioid analgesics, use of parenteral and oral NSAIDs is becoming more popular for postoperative pain relief and diclofenac is one of them. [7] [8] [9] Diclofenac is an analgesic-antipyretic-antiinflammatory drug. It inhibits prostaglandins synthesis by inhibiting cyclooxygenase enzyme. Parenteral route (IM) of admission is most commonly employed for pain relief. But it had a lot of shortcoming and may produce discomfort on injection and undesirable side effects like nausea and vomiting. Other alternative routes include intravenous (IV), suppository, and transdermal route. Transdermal route has advantage of being painless, nonirritant, and increase bioavailability. 10 Though transdermal route has distinct advantage over parenteral route, there are very less studies which compared transdermal and parenteral route in patient undergoing abdominal hysterectomy. So the present study was undertaken in patients undergoing elective abdominal hysterectomy, under subarachnoid block with an objective to evaluate the efficiency, patient's tolerability, adverse events of transdermal diclofenac patch with IM diclofenac for postoperative analgesia.
MATERIALS AND METHODS
After Institutional Review Board approval and written informed consent from patient, this prospective, randomized, clinical trial was carried out in patients of 40 to 80 years of age, belonging to ASA physical status I, II, having body mass index (BMI) ≤ 30 kg/m 2 and scheduled for elective abdominal hysterectomy under spinal anesthesia at Sir Takhtsinhji Hospital, Bhavnagar, Gujarat, India. Patients with peripheral neuropathy, allergy to local anesthetics or drug used in study, history of acid peptic disease, coagulopathy, cardiovascular disease, and refusing to participate were excluded from the study.
Preoperative Preparation
The enrolled patients were randomly allocated by computer-generated random number sequence in one of the two groups. Group TP (n = 30): Transdermal diclofenac patch of 100 mg was applied 3 hours before start of surgery.
Group IM (n = 30): Diclofenac sodium 75 mg (3 mL) by IM route was given half an hour before end of surgery.
Transdermal or IM diclofenac were repeated 12 hours later.
The patients were kept nil by mouth since 10.00 pm night before the surgery. In preanesthetic preparation room monitoring for vital parameters like heart rate (electrocardiogram), mean arterial pressure (noninvasive blood pressure), peripheral oxygen saturation (pulse oximeter) were established and IV line was secured with 18G cannula.
Premedication
• Tablet Alprazolam 0.5 mg on night before surgery.
• Midazolam 1 mg IV 30 minutes prior to surgery.
For surgery, under strict aseptic and antiseptic precautions patients were given subarachnoid block in lateral position in L3 to L4 intervertebral space using 25G spinal needle with 3.5 mL of 0.5% hyperbaric bupivacaine.
Postoperatively, pain was assessed using VAS scores for the next 24 hours every 2 hourly. The goal is to keep VAS ≤ 4. If any time VAS is >4, tramadol 2 mg/kg IV will be given as rescue analgesic.
Minimum standard monitoring was continued up to 24 hours. Visual analog scale, use of rescue analgesia, patient satisfaction score (excellent = 3, good = 2, poor = 1) and complication (nausea/vomiting, abdominal pain, hypotension, urinary retention, itching, dislodgement/ loosen/peel off, local site reaction and injection pain) if any were noted postoperatively for the next 24 hours every 2 hourly.
Visual Analog Score
The VAS score is a psychometric response scale which is subjective. When responding to VAS system respondent specify their level of agreement to a statement by indicating a position along a continuous line between to end position. 
Statistical Analysis
Considering postoperative analgesia as the main outcome measure of interest in this study with at least 10% efficacy shown by the study group, minimum 20 patients are required per group with the permitted alpha error of 0.05 and beta error of 0.2. With permitted beta error of 0.2, the power of study stands out to be 80%. To overcome with data loss, study dropouts, and exclusion criteria, we enrolled total of 60 patients. Data collected were analyzed as mean ± standard deviation (SD) and percent whichever applied. Statistical analysis was done by Graphpad Instat 3.0 software. Intergroup comparison between two groups jorapain was done using the unpaired Student's t-test for quantitative data and chi-square test for qualitative data (p < 0.05 was considered as statistically significant). Table 1 , patient characteristics in terms of age, weight, height, and ASA physical status were comparable among the two groups of patients. Duration of surgery was also comparable in the two groups (p > 0.05).
RESULTS

As shown in
Visual Analog Scale Pain Score
Comparison of VAS score at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 hours was comparable in each group and difference was not significant statistically (p > 0.05; Table 2 and Graph 1).
Rescue Analgesics
In group TP, majority of the patients required rescue analgesics between 9 and 16 hours. In group IM, majority of the patients required rescue analgesics between 0 and 8 hours Graph 2.
Doses of Rescue Analgesics Required in 24 Hours
On comparison of doses of rescue analgesia required, five patients in each group required one injection of rescue analgesia, while one patient in each group required two injections in 24 hours. Hence, there was statistically no significant difference in total dose of rescue analgesics required in group TP as compared with group IM.
Patient Satisfaction Score
Patient's mean satisfaction score at postoperative day 1 was comparable in each group and not significant statistically (p > 0.05).
Vitals
Comparison of patients heart rate, pulse, oxygen saturation, and respiratory rate at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 hours was done in each group and difference was not statistically significant (p > 0.05).
Complications
The diclofenac patch was well tolerated with one minor case of erythema and redness. In diclofenac IM injection treated group, three cases (10%) show signs of erythema, induration, and edema associated with moderate pain, another three cases (10%) of gastric upset (abdominal pain and heart burn) have been reported (Table 3) .
DISCUSSION
Postoperative pain remains an important area of research for introduction of new modalities of treatment with enhanced effectiveness at the same time with lesser side effects. The advantages of effective postoperative pain management include patient comfort and therefore, satisfaction, earlier mobilization, a reduced risk of deep vein thrombosis, fewer pulmonary and cardiac complications, faster recovery, reduced patient morbidity, reduced cost of care, and improve the overall patient's outcome. Despite the obviously simple nature of surgical incision, however, perioperative and specifically postoperative pain remain under evaluated and poorly treated. Recent surveys suggest that 80% of patients experience pain after surgery, 11% having severe pain, and that pain delays recovery in 24% of patients undergoing ambulatory surgery. The possible reason could be distinct mechanism of incisional nociception, compared with other painful conditions. Another reason might be lack of knowledge in-depth regarding the pathophysiology and neuropharmacology of postoperative pain. Postoperative pain should be cured to alleviate nociception induced responses, such as the endocrine, metabolic, and inflammatory responses to surgery which activate autonomic reflexes with adverse effects on organ function and reflexes leading to muscle spasm. 11 The autonomic overactivity results in increase in heart rate, peripheral vascular resistance, arterial blood pressure, and myocardial contractility which culminates increased oxygen consumption from increased cardiac work. The combination of increased myocardial oxygen demand and decreased oxygen supply can be detrimental in patients with coronary artery disease and may lead to myocardial ischemia and infarction. 12 Untreated or poorly treated postoperative pain increases incidence of nausea and vomiting. Increased sympathetic activity can lead to increased urinary sphincter tone and subsequent urinary retention. 12, 13 The somatic pathway stimulation activates hypothalamic-pituitary axis, which is followed by secretions of pituitary hormones. The limitation of movement caused by pain leads to marked impairment in muscle metabolism, resulting in muscle atrophy, fatigue, and delayed return to normal muscle function. 12, 13 Psychological consequences due to inadequate pain relief include anxiety, fear, anger, depression, and reduced patient satisfaction as well. So, it is a prime duty of an anesthesiologist to provide postoperative analgesia to make patient more comfortable and relax after surgery. Total abdominal hysterectomy is considered to be a major surgery with moderate to severe postoperative pain levels, with a small percentage of women suffering from chronic pain latter on, possibly as a result of inadequately treated acute pain after surgery.
14-17 Also this surgery can be done, both under regional and general anesthesia, depending on how extensive the surgery is and the preference of the patient and surgeon. Although opioids are effective postoperative analgesics, but their efficacy is often limited by the development of tolerance, physical dependence, potential hazards of over sedation, and respiratory depression. 18 Among the nonopioid group of drugs, NSAIDs have gained increasing popularity in treating postoperative pain, especially diclofenac. The actions of diclofenac appear to be associated principally with the inhibition of prostaglandin synthesis-by inhibiting cyclooxygenase-the enzyme that catalyzes the formation of prostaglandin precursors (endoperoxides) from arachidonic acid. Alone or in combination with opioids they decrease postoperative pain. Topical application of NSAIDs has been reported to be effective in decreasing both acute and chronic pain. 19 Parenteral or oral administration of diclofenac has its own adverse effects and it also carries boxed warnings. Transdermal patch, which is a new innovation in the drug delivery system, offers many advantages, such as painless administration of drug, increased bioavailability, maintenance of constant and prolonged drug level, reduced frequency of dosing, minimization of inter-and intrapatient variability, easy self-administration and easy termination of medication, leading to better patient compliance. 20 It also offers a good option for those patients who are unable to administer drug orally. In addition, topical NSAIDs have been associated with a lower incidence of gastrointestinal adverse effects compared with systemic administration of this medication. 21 As it bypasses first pass metabolism in the liver, a transdermal drug administration also overcomes concerns regarding drugs that are poorly absorbed in the gastrointestinal tract. As safety is concerned, topical NSAIDs have potential advantage over parenteral NSAIDs. In one study, the authors demonstrated that because of low systemic concentrations, topical NSAIDs have a 22 But an important concern with regard to transdermal drugs delivery is its prolonged duration of onset and offset compared with IV or IM medication which can be used as when needed to control pain. 23 This disadvantage can be overcome by proper planning and careful timing schedule before application in order to get effective results. Therefore, we have applied transdermal patch 3 hours before the start of surgery. In patients scheduled for surgery, these agents are applied prior to the surgical intervention, i.e., in anticipation to pain and not after the patient experiences pain, this is due to the long duration of its onset. The present study shows that analgesic efficacy (using VAS score) was comparable in both the groups and the result of this study was comparable with previous studies. 20, [24] [25] [26] [27] [28] One study showed that transdermal patch had better analgesic efficacy than diclofenac IM injection, 29 while
another study had superior result with IM injection. 30 Patient's mean satisfaction score, in the present study at postoperative day 1, was comparable in each group (p > 0.05).
Regarding requirement of rescue analgesia, 6 patients (20%) in each group required rescue analgesia, though the timing of rescue analgesia was different. The VAS score is subjective measurement of pain. So, individual variability in pain perception, lower threshold of pain in some patient may cause more requirement of rescue analgesia in such patients.
Safety analyses revealed no apparent serious adverse effects with transdermal patch. The safety profile of diclofenac patches has also been emphasized by Mason et al, 31 in their systematic review on the use of topical NSAIDs in the UK and by studies reporting the use of the diclofenac transdermal patch in osteoarthritis as well as in sports-related injuries. Lower plasma concentration achieved with topical NSAID application is associated with reduction in systemic adverse effects. Though we did not calculate the cost-effectiveness between the two groups which can be the limitation of our study, it is obvious that IM injection is cheaper than transdermal patch.
Our study results revealed that when applied 3 hours before surgery, a diclofenac 100 mg transdermal patch had effectively reduced postoperative pain in patients of abdominal hysterectomy. Based on our observations, with proper time schedule, application of transdermal diclofenac patch in postoperative patients of abdominal hysterectomy can be considered as efficient as diclofenac IM injection in terms of analgesia.
